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Zinger oﬃcinale has been used as a traditional source against gastric disturbances from time immemorial. The ulcer-preventive
properties of aqueous extract of ginger rhizome (GRAE) belonging to the family Zingiberaceae is reported in the present study.
GRAE at 200mgkg−1 b.w. protected up to 86% and 77% for the swim stress-/ethanol stress-induced ulcers with an ulcer index
(UI) of 50 ± 4.0/46 ± 4.0, respectively, similar to that of lansoprazole (80%) at 30mgkg−1 b.w. Increased H+,K +-ATPase activity
and thiobarbituric acid reactive substances (TBARS) were observed in ulcer-induced rats, while GRAE fed rats showed normalized
levels and GRAE also normalized depleted/ampliﬁed anti-oxidant enzymes in swim stress and ethanol stress-induced animals.
Gastric mucin damage was recovered up to 77% and 74% in swim stress and ethanol stress, respectively after GRAE treatment.
GRAE also inhibited the growth of H. pylori with MIC of 300 ± 38μg and also possessed reducing power, free radical scavenging
ability with an IC50 of 6.8 ± 0.4μgmL −1 gallic acid equivalent (GAE). DNA protection up to 90% at 0.4μg was also observed.
Toxicity studies indicated no lethal eﬀe c t si nr a t sf e du pt o5gk g −1 b.w. Compositional analysis favored by determination of the
eﬃcacy of individual phenolic acids towards their potential ulcer-preventive ability revealed that between cinnamic (50%) and
gallic (46%) phenolic acids, cinnamic acid appear to contribute to better H+,K +-ATPase and Helicobacter pylori inhibitory activity,
while gallic acid contributes signiﬁcantly to anti-oxidant activity.
1.Introduction
More and more evidences are being accumulated nowadays
regarding the cause of gastric hyperacidity and ulcers. Stress
appear to play a major role as indicated by a set of studies
which emphasizes that any patient irrespective of the nature
ofthedisease,ifadmittedtoemergencywardsinthehospital,
invariably ends up with gastric ulcers [1].
Besides this there are characteristic problems such as
(i) Zollinger-Ellisson syndrome where there is a high and
uncontrolled production of acid; (ii) the use of non-steroidal
anti-inﬂammatory drugs [2] (NSAID) for rheumatoid dis-
eases and (iii) a rod-shaped pathogenic bacteria Helicobacter
pylori, normally existing in human stomach are known to
causeulcers[3].Ulcerationmayoccureitherbyuncontrolled
production of acid or by the side eﬀects of NSAIDs which
acts as inhibitors of gastric mucosal defense or by manip-
ulating the mucosal epithelium structure-function causing
a defenseless condition and hence ulcers. The concept of
management of ulcer disease is fast changing. Treatment
was based on the principle that excessive secretion of acid
is the reason for ulcer symptoms. However, understanding
the role of histamine, gastrin and acetylcholine in addition
to gastric acid in controlling gastric secretion lead to the
designing of anti-ulcer drugs which act as blockers of
such receptors. The role of enzymic gastric proton pump
with H+,K +-ATPase activity is very crucial in varieties of
ulcers irrespective of the root cause [4]. Therefore, blockers
of H+,K +-ATPase has been considered and explored to
design anti-ulcer drugs such as omeprazole, lansoprazole,
etc. However, these proton pump blockers are documented







































Scheme 1: Ulcerogens generate oxidative stress (OS) leading to susceptibility for ulcer formation by activating H+,K +-ATPase, enabling H.
pylori colonization and invasion, mucosal damage, and so forth, ginger downregulates these events.
non-steroidal anti-inﬂammatory drugs, pregnancy, lacta-
tion and alcoholic consumption. Current article therefore
addresses an alternative source for the potential ulcer cure,
addressing the use of common dietary sources for eﬀective
prevention or healing of ulcerations (Scheme 1). Further, it
is pertinent to address this question because in traditional
medicine for which ginger had a high grade; its potency
needs to be evaluated in vivo in the form it is used in
traditional medicine (aqueous extract of ginger—GRAE).
Ginger (Zingiber oﬃcinale Roscoe.) is cultivated mainly
foritsrhizome,whichisapopularspiceinIndiancontinental
cuisine and an equally popular compound in national
medicine. The proximate chemical composition of ginger
has been shown to contain ∼1–4% of volatile oils, which
are the medically active constituents of ginger. Ginger has
been reported to exert anti-oxidant and anti-ulcer [6],
anti-inﬂammatory, anti-tumor [7], carminative, diaphrodic
and digestive, expectorant, as well as gastro protective [8]
activities. The phenols detected in solvent extracts of ginger
were mainly gingerol and zingerone. Recently, we reported
that phenolic acids play a major role in inhibiting parietal
cell H+,K +-ATPase, inhibition of an ulcerogen—H. pylori,
exhibiting anti-oxidative properties in vitro [9]. Current data
provides evidence for the potential ulcer-preventive ability
of phenolics in ginger aqueous extract and addresses the
probable mode of action.
2.MaterialsandMethods
2.1. Chemicals. Adenosine triphosphate (ATP), glutathione
reductase, nitroblue tetrazolium (NBT), 2-thiobarbituric
acid(TBA),lanzoprazolewerepurchasedfromSigmaChem-
ical Co. (St Louis, MO, USA). Hexane, hydrochloric acid,
trichloroacetic acid (TCA) and solvents used were of the
analytical grade purchased from local chemical company
(Sisco Research Laboratories, Mumbai, India).
2.2. Plant Material and Preparation of Aqueous Extract. Gin-
ger (Z. oﬃcinale Roscoe.) rhizome was purchased from the
local market at Mysore, India and used for studies. One kilo-
gram fresh ginger rhizome was cleaned, washed under run-
ning tap water, cut into small pieces, air dried, powdered for
particle size of 20 mesh and Ginger powder (10g) was defat-
tedusinghexaneinasoxhletapparatus.Onegramofdefatted
powder was taken in 10mL distilled water and boiled for
5min, cooled and centrifuged at 1000g for10min. The clear
supernatant was separated and referred as ginger aqueous
extract (GRAE). A total yield of 8g/100g accounting to an
averageof8%(w/w)wasobtainedwithtriplicateextractions.
Obtained aqueous extract was analyzed for bioactivity—
anti-oxidants, inhibition of H+,K +-ATPase/H. pylori.
2.3. Assessment of Anti-Ulcer Potential of GRAE against
Swim/Ethanol Stress-Induced Ulcers. Wistar albino rats
weighing about 180–220g maintained under standard con-
ditions of temperature, humidity and light were provided
with standard rodent pellet diet (Amruth feeds, Bangalore,
India) and water ad libitum. The study was approved by the
institutional ethical committee, which follows the guidelines
of CPCSEA (Committee for the Purpose of Control and
Supervision of Experiments on Animals, Reg. No. 49, 1999),
Government of India, New Delhi, India.
All the animals were categorized into two sets of ﬁve
groups of six numbers each (n = 6). GRAE with two doses of
100 and 200mgkg−1 b.w. and lansoprazole 30mgkg−1 b.w.
wereadministeredorallytwicedailyfor14days.Attheendof
14th day animals were fasted for 18h before inducing ulcer.
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per the known protocol [10], while in second set, animals
were subjected to ethanol stress [11]. Animals were sacriﬁced
under deep ether anesthesia; stomach/liver was removed and
used for enzyme assays. Serum was collected from the blood
of all animals and analyzed for various parameters. Ulcer
index was determined as described in our previous paper
[12]. Stomach and liver tissues were homogenized in chilled
Tris-buﬀer (10mM, pH 7.4) at a concentration of 5% (w/v).
The homogenates were estimated for protein [13], anti-
oxidant, anti-oxidant enzymes—catalase, superoxide dismu-
tase (SOD), glutathione peroxidase and TBARS as described
previously [14] and compared between groups of animals.
2.4. Assessment of H+,K +-ATPase. Equal weight of gastric
tissue from animals of each group was homogenized using
Tris-HCl buﬀer pH 7.4. The gastric membrane vesicles
enriched in H+,K +-ATPase were prepared and the H+,K +-
ATPase activity was assessed as described previously [12].
The enzyme extract (350μgmL −1)w a st a k e ni na
reaction mixture containing 16mM Tris buﬀer (pH 6.5)
and the reaction was initiated by adding substrate 2 mM
ATP, in addition to 2mM MgCl2 a n d1 0 m MK C l .A f t e r
30min of incubation at 37◦C, the reaction was stopped by
the addition of assay mixture containing 4.5% Ammonium
molybdate and 60% Perchloric acid. Inorganic phosphate
formed was measured spectrophotometrically at 400nm.
Enzyme activity was calculated as μmoles of inorganic
phosphate (Pi) released/h.
2.5. Determination of Gastric Mucin. Gastric mucin was
isolated from the glandular segments of stomach and quan-
titated employing a monoclonal anti-human gastric mucin
antibody (MAb-GM) by ELISA [15]a sw e l la sb yA l c i a nb l u e
dye binding methods [16].
2.6. Toxicity Studies. Toxicity studies were carried out in
Albino Wistar rats, kept at controlled environment and
acclimatized to laboratory conditions for 1 week before
study.Rats(180–220g)wereorallyfedoncedailywithGRAE
(2gkg−1 b.w.) for 14 days. The control group received the
vehicle(distilledwater)only.Twenty-fourhoursafterthelast
dose, number of animals survived were noted and sacriﬁced
by cervical dislocation, blood was collected and serum was
used for estimation of TBARS, total protein and enzymes
related to liver function tests—serum glutamate pyru-
vate transaminase (SGPT), serum glutamate oxaloacetate
transaminase (SGOT), and alkaline phosphatase (ALP)]
using standard protocols [15].
2.7. Anti-Helicobacter pylori Activity. Helicobacter pylori was
obtained by endoscopic samples of ulcer patients from
KCDC (Karnataka Cardio Diagnostic Centre, Mysore, India)
and cultured on Ham’s F-12 nutrient agar medium with 5%
FBS at 37◦C for 2-3 days in a microaerophelic condition.
Helicobacter pylori culture was characterized by speciﬁc tests
such as urease, catalase, oxidase, gram staining, colony char-
acteristics and morphological appearance under scanning
electronmicroscopeandalsoconﬁrmedbygrowthofculture
in presence of susceptible and resistant antibiotics.
2.8. Agar Diﬀusion Assay. Helicobacter pylori activity was
tested by the standard agar diﬀusion method [17]B r i e ﬂ y ,
the petriplates were prepared with Ham’s F-12 nutrient agar
media containing 5% FBS inoculated with 100μLo fH.
pylori culture (105 cellsmL−1). Sterile discs of high-grade
cellulose of diameter 5.5mm were impregnated with 20μL
of known extract (0.25–1.0mgdisc−1)o fG R A Ep l a c e do n
the inoculated petriplates. Amoxicillin was used as positive
reference standard and 0.9% saline as negative control.
For comparative evaluation discs containing 10μge a c ho f
amoxicillin, GRAE was performed in addition to the control.
Helicobacter pylori growth inhibition was determined as
the diameter of the inhibition zones around the discs.
The growth inhibition diameter was an average of four
measurements taken at four diﬀerent directions and all tests
were performed in triplicates.
2.9. Minimal Inhibitory Concentration. Minimal inhibitory
concentration (MIC) values were determined by conven-
tional broth dilution method [17]. Serial dilutions (ﬁnal
volume of 1 ml) of GRAE (50–500μgmL −1) were performed
with0.9%saline.Followingthis,9mLofHam’sF-12nutrient
medium with 5% FBS was added. Broths were inoculated
with 100μLo fH. pylori suspension (5 × 104 CFU) and
incubatedfor24hat37◦C.Amoxicillinwasusedasapositive
control since H. pylori is susceptible to amoxicillin and
0.9% saline as negative control. After 24h, H. pylori growth
was assayed by measuring absorbance at 625nm. MIC was
deﬁned as the lowest concentration in μg of GAE to restrict
the growth to <0.05 absorbance at 625nm (no macroscopic
visible growth).
2.10. Scanning Electron Microscopy. The bacterium was
grown overnight in broth at 37◦C and 100μL( 8l o g 10 CFU
mL−1) in 5mL broth medium were incubated with
amoxicillin (10–30μgmL −1) or GRAE (50–200μgmL −1)
and major phenolic acids such as cinnamic, gentisic, ferulic
and gallic acids (10–50μgmL −1)f o r6 ha t3 7 ◦C and the
suspension without treatment was taken as control. After
incubation, 100μL aliquot was processed for scanning
electron microscopic studies as described earlier [18].
Multiple ﬁelds of visions were viewed and results were
documented by photography at diﬀerent magniﬁcations.
2.11. HSA-Phenolics Interaction Studies. S t o c ks o l u t i o no f
human serum albumin was prepared to a concentration of
1.0×10
−4 MinTris-HClbuﬀerofpH7.4containing100mM
sodium chloride. All the phenolic compounds were prepared
to a concentration of 10mg/100mL in ethanol (95%)
because ethanol has no ﬂuorescence and does not aﬀect the
determinations. All ﬂuorescence measurements were made
in a Shimadzu RF-5301PC spectroﬂuorophotometer.
A series of assay solutions were prepared by adding
10μL of the stock solution of HSA and varied concen-
trations of phenolics (0.5–2.5μgmL −1) into each marked4 Evidence-Based Complementary and Alternative Medicine
tube respectively, and diluted to the mark 1.0mL with
Tris-HCl buﬀer of pH 7.4. The concentration of HSA
was constant and the possible interaction was studied at
diﬀerent concentrations of phenolic acids. Tubes were mixed
thoroughly and placed in the thermostat water-bath at
37◦C for 5min, and transferred to the quartz cuvette and
ﬂuorescence emission spectra were recorded in the wave-
length range 290–500nm by exciting HSA at 280nm using
a slit width of 5/5nm. Wavelength nearer to shift observed
was recorded to understand the involvement of trypto-
phan/tyrosineresidueinHSAandwereexpressedasSterner’s
constant.
2.12. Measurement of Anti-Oxidant Activity in GRAE
2.12.1. Free Radical Scavenging Activity. The anti-oxidant
activityofGRAEonthebasisofthescavengingactivity ofthe
stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical,
was determined by the method described by Braca et al. [19].
An aliquot of 100μL of GRAE at various concentrations-
2.5–15μgmL −1 were added to 3mL of 0.004% methanol
solution of DPPH. The mixture was shaken vigorously and
left to stand for 20min at room temperature in the dark.
The absorbance of the resulting solution was measured
spectrophotometrically at 517nm. The capability to scav-
enge the DPPH radical was calculated using the following
equation.
Scavenging effect (%) =
Absorbance of control at 517 nm −Absorbance of sample at 517 nm
Absorbance of control at 517 nm
× 100, (1)
2.12.2. Reducing Power Ability. The reducing powers of
GRAE were determined according to the method of Yen and
Chen [20]. The extract of GRAE (5–25μgmL −1)w e r em i x e d
with an equal volume of 0.2M phosphate buﬀer, pH 6.6 and
1% potassium ferricyanide. The mixture was incubated at
50◦C for 20min. An equal volume of 10% TCA was added
to the mixture, centrifuged at 3000g for 10min. The upper
layer of solution was mixed with distilled water and 0.1%
FeCl3 at a ratio of 1:1:2 (v/v/v) and the absorbance was
measured at 700nm. Increased absorbance of the reaction
mixture indicated increased reducing power.
2.12.3. Inhibition of Lipid Peroxidation of Rat Liver Hom-
ogenate. In vitro lipid peroxidation levels in rat liver homo-
genate was measured as TBARS. Ten percent of fresh liver
homogenate was prepared in 20mM phosphate buﬀer saline
(PBS), pH 7.4 (36). Brieﬂy, 0.25mL of liver homogenate
was incubated with 5–25μgmL −1 of GRAE in 20mM
PBS, pH 7.4. After 5min of pre-treatment, 0.5mL each of
ferric chloride (400mM) and ascorbic acid (400mM) was
added and incubated at 37◦C for 1h. The reaction was
terminated by addition of 2.0mL of TBA reagent (15%
TCA, 0.37% TBA in 0.25N HCl) and tubes were boiled for
15min at 95◦C, cooled, centrifuged and read at 532nm.
TBARS was measured by using a standard TMP (1,1,3,3
tetramethoxy propane) calibration curve (0.1–0.5μg) and
expressed as percent inhibition of lipid peroxidation by
extracts.
2.12.4. DNA Protection Assay. T h eD N A - p r o t e c t i v ee ﬀect of
phenolic fractions was determined electrophoretically (Sub-
marine electrophoresis system, Bangalore Genei, Bangalore,
India) using calf thymus DNA (37). Calf thymus DNA (1μg
in 15μL) was subjected to oxidation by Fenton’s reagent
(30mM H2O2,5 0 m Ma s c o r b i ca c i da n d8 0 m MF e C l 3).
Relative diﬀerence in the migration between the native and
oxidizedDNAwasensuredon1%agarosegelelectrophoresis
afterstainingwithethidiumbromide.Gelsweredocumented
(Herolab, Germany) and the intensity of the bands was
determined (Easywin software). Protection to DNA was
calculated based on the DNA band corresponding to that
of native in the presence and absence of 2 and 4μgo f
GRAE.
2.13. Determination of the Phenolic Content and Com-
position in GRAE. The total phenolic content in GRAE
was determined using Folin-Ciocalteu reagent as described
earlier [21]. Gallic acid was used as standard for the
generation of calibration curve. Total phenolic content was
expressed as Gallic Acid Equivalents (GAE) in mgg−1 of
GRAE.
Phenolic acids from GRAE were analyzed by HPLC
(modelLC-10A.ShimadzuCorp,Kyoto,Japan)onareversed
phase Shimpak C18 column (4.6 ×250mm, Shimadzu Corp,
Kyoto, Japan) using a diode array UV-detector (operating
at λmax 280nm). A solvent system consisting of water/acetic
acid/methanol (isocratic, 80:5:15v/v/v) was used as mobile
phase at a ﬂow rate of 1mLmin−1 [22]. Phenolic acid
standards such as caﬀeic, coumaric, cinnamic, ferulic, gallic,
gentisic, protocatechuic, syringic and vanillic acids were
employed for identiﬁcation of phenolic acids present in
GRAE by comparing the retention time under similar
experimental conditions.
2.14. Statistical Analysis of Data. All the experiments were
carriedoutintriplicatesandtheresultsareexpressedasmean
value ± SD. P-value was calculated by the Mann-Whitney
test. Duncan’s New Multiple Range Test was performed to
understand the degree of signiﬁcance between controls and
treated samples.Evidence-Based Complementary and Alternative Medicine 5
3. Results
3.1. Ulcer-Preventive Eﬀect of GRAE in Swim-Stress-/Ethanol-
Induced Ulcer Animal Model. Ulcer-preventive eﬀect of
GRAE was evaluated by using swim/ethanol stress-induced
ulcers. These two models are well-accepted oxidative
stress-induced ulcerations model. Mechanism of induction
although in both the cases mediated by reactive oxygen
species (ROS), in swim stress, it is more through initiation
of parietal cell- H+,K +-ATPase activation, while in ethanol
it is via damage of mucosal epithelium. Figure 1(a) depicts
the stomach of healthy rat which showed no damage or
lesions. In swim/ethanol stress-induced ulcers, the lesions
were characterized by multiple hemorrhagic red bands of
diﬀerent size along the long axis of the glandular stomach
(Figures 1(b) and 1(c)). Oral treatment of GRAE at 100
and 200mgkg−1 b.w. as well as lansoprazole at 30mgkg−1
b.w. showed protection in a dose-dependent manner with
no intraluminal bleeding and insigniﬁcant number of gastric
lesions(Figures1(e),1(f),1(h)and1(i)).Quantitativereduc-
tion in ulcer index in treated rats compared to either ulcer
induced or healthy is calculated and depicted in Figure 1(j).
Data indicated that GRAE protected dose dependently up to
77–86% protection at 200mgkg−1 b.w.
3.2. Evaluation of GRAE Potential on Oxidant and Anti-
Oxidant Status in Ulcerous and Treated Animals. A2 -t o
2.4-fold increase in SOD and GPX levels in stomach tissue
were observed in swim/ethanol stress-induced animals and
were normalized upon treatment with GRAE in a dose-
dependent manner. Whereas, CAT and GSH decreased to
1.6-fold during stress-induced ulcerous conditions were
normalized upon treatment with GRAE as shown in Tables
1 and 2. Approximately 2.6-fold increase in TBARS levels
indicated the lipid peroxidation or damage of stomach tissue
in ulcerous animals; and was recovered up to 91% upon
treatment with GRAE. A 2- to 2.3-fold increase in TBARS
levels observed in serum and liver homogenate of stress-
induced ulcerous groups was recovered also up to 75% upon
GRAE treatment at 200mgkg−1 b.w.
3.3. H+,K +-ATPase Inhibition and Mucin Protection by
GRAE. The elevated levels of H+,K +-ATPase in swim stress
and ethanol stress was normalized upon treatment with
GRAE in a dose-dependent manner. Oral pre-treatment of
GRAE inhibited the H+,K +-ATPase activity and showed
3.1- and 2.9-fold reduction at 200mgkg−1 b.w. In case
of lansoprazole, slightly decreased level of H+,K +-ATPase
activity was observed (Table 3) and the results were also
validated by in vitro assay—inhibition of H+,K +-ATPase
enzyme from sheep stomach parietal cells. GRAE inhibited
H+,K +-ATPase activity with an IC50 of 16.5 ± 1.2μgG A E
as opposed to that of lansoprazole (19.3 ± 2.2μgw / w )
indicating increased potency of GRAE. Further, the damaged
mucin in ulcerous condition was protected up to 68–72%
upon treatment with GRAE at 200mgkg−1 b.w (Table 3).
3.4. Toxicity Studies with GRAE. Toxicity studies with aque-
ous solution of GRAE were carried out in rats for safety
evaluation indicated no lethal eﬀect upto 1 gkg−1 b.w. when
orally fed for 14 days. There were no signiﬁcant diﬀerences
in total protein, TBARS levels, SGPT, SGOT and ALP
between normal and GRAE-treated rats (Table 4) indicating
no adverse eﬀect on the major organs. Animals after above
treatment schedule remained healthy as that of control
animalswithnormalfoodandwaterintake,bodyweightgain
and behavior.
3.5. Anti-Helicobacter pylori Activity of GRAE. The bacte-
ria isolated from endoscopic samples were Gram-negative,
motile and showed positive for urease, catalase and oxidase
tests (Table 5). Further, it was conﬁrmed by the response to
antibiotics asitwasresistanttoantibiotics like erythromycin,
nalidixic acid, polymixin B, penicillin and vancomycin
and was susceptible to amoxicillin, clarithriomycin and
metronidazole. The appearance of a characteristic white
mucilaginous colony conﬁrms the identity of bacteria as H.
pylori.
In the agar diﬀusion method, GRAE showed a clear
inhibition zone around the disc at 50μgmL −1 concentration
equivalent to that of a susceptible antibiotic amoxicillin at
10μgmL −1 (Figure 2(a)). MIC values determined by broth
dilution method indicated signiﬁcant anti-H. pylori activity
at 300 ± 38μgmL −1 at P ∼ .003.
SEM observation revealed the eﬃcacy of GRAE action
in inhibiting the H. pylori growth. Figure 2(b) shows the
uniform rod-shaped normal H. pylori cells, whereas the cells
treated with amoxicillin, GRAE, gallic and cinnamic acid
changed from helical form to coccoid and became necrotic
(showed with arrows in Figures 2(c)–2(f)). Coccoid form
with blebs in the bacterial surface, appearance of vacuoles,
granules and an area of low electron density in the cytoplasm
(showed with arrow marks) were observed in GRAE-treated
sample indicating the lysis of H. pylori. Results were also
substantiated by viability test, which indicated the loss of
85% viability upon treatment with GRAE supporting anti-
microbial nature of GRAE.
3.6. Multipotent Anti-Oxidant Activity of GRAE. The ginger
aqueous extract possessed 7.6 ± 0.5mgGAE/g phenolics.
The HPLC analysis of GRAE revealed that cinnamic acid
(50%) and gallic acid (46%) were the major phenolic acids
with small amounts of caﬀeic, ferulic, gentisic, protocat-
echuic, syringic and vanillic acids (Figure 3). The total
reducing power ability of GRAE was ∼1168 ± 90Ug−1
GAE (Figure 4(a)) and Figures 4(b) and 4(c) illustrates the
scavenging eﬀect of GRAE on DPPH radical and inhibition
of lipid peroxidation at IC50 6.8 ± 0.4μgmL −1 GAE and
16.8 ± 1.2μg GAE, respectively. GRAE also exhibited DNA
protective ability (Figure 5); the damaged DNA migrated
fast, while protected DNA moved slowly as that of normal,
untreated DNA. Image analysis indicated recovery of DNA
up to >90%.
3.7. HSA Interaction. Since there was a signiﬁcant reduction
in H+,K +-ATPase which could be attributed to phenolics6,
current study attempted to explore the possible binding of

























































Figure 1: Macroscopic observation of Ulcers in ulcer induced/protected stomachs in swim stress-/ethanol stress-induced ulcer models.
Ulcer was induced in animals by either swim stress (SS) or ethanol stress (ES) in group of pre-treated/untreated animals at indicated
concentrations. In healthy control (a) no ulcer lesions or damage in the stomach tissue was observed. In ethanol stress (b) and swim
stress (c) induced animals, ulcers score were very high. Lansoprazole (d, g) and GRAE at 100 and 200mgkg−1 treated animals showed
dose-dependent reduction in stomach lesions (e, f, h, i). (j) Maximum ulcer index observed during stress induction was controlled in a
concentration-dependent manner. Reduction in ulcer index and percent protection is depicted.Evidence-Based Complementary and Alternative Medicine 7
Table 1: Anti-oxidant/anti-oxidant enzymes and TBARS levels in swim stress-induced ulcer model (n = 6) mean ± SD.
Parameters Protein (mgg−1) SOD (Umg−1) Catalase (Umg−1) Glutathione
Peroxidase (nmol g−1)
GSH (Umg−1)T B A R S n m o l
Stomach
Healthy 2.23c ±0.16 092.9a ±08 46.5c ±4.6 28.6a ±2.4 376.6c ±37 0.82a ±0.07
Ulcerated 1.39a ±0.16 201.3d ±21 22.8a ±2.1 68.6c ±5.6 216.2a ±23 2.16c ±0.19
GRAE 100 mg kg−1 1.68a ±0.16 161.6c ±18 38.6b ±3.4 32.4b ±3.5 306.5b ±32 1.12b ±0.08
GRAE 200 mg kg−1 2.46b ±0.23 136.4b,c ±14 43.1b,c ±4.5 26.9a ±2.8 351.5c ±34 0.91a ±0.06
Lansoprazole 2.13b ±0.13 124.3b ±14 44b,c ±4.5 26.7a ±2.3 325b,c ±32 0.94a ±0.08
Serum
Healthy 6.621a ±0.51 112.3a ±28 44.20c ±4.9 0.221a ± 0.004 23.6c ±3.00 .165a ±0.01
Ulcerated 6.845a ±0.53 264.6d ±32 22.90a ±3.1 0.286c ±0.02 11.1a ±1.80 .326d ±0.02
GRAE 100 mg kg−1 6.663a ±0.62 186.8c ±21 34.23b ±3.6 0.293d ±0.03 16.5b ±1.70 .264c ±0.02
GRAE 200 mg kg−1 6.943a ±0.61 148.6b ±15 41.45c ±4.3 0.254b ±0.03 22.3b,c ±2.30 .186a,b ± 0.02
Lansoprazole 6.632a ±0.62 143.6b,c ±16 36.82b ±3.4 0.246a ±0.02 18.8a ±2.30 .188b ±0.01
Liver
Healthy 24.2c ±0.31 261.5b ±41 28.42d ± 3.1 0.32a ± 0.02 414c ±51 0.98a ±0.13
Ulcerated 21.9a ±0.23 142.4a ±18 22.18b,c ±2.6 0.58c ±0.05 221a ±26 2.41d ±0.23
GRAE 100 mg kg−1 23.7b ±0.27 196.6a ±21 22.54b,c ±2.4 0.45a,b ±0.04 323b ±33 1.98c ±0.21
GRAE 200 mg kg−1 24.2b ±0.23 266.7d ±36 26.67a ±2.4 0.46a ± 0.04 382a ±36 1.45b ±0.27
Lansoprazole 23.7b ±0.25 234.4c,d ±24 24.62a ±2.3 0.41a ± 0.03 325a ±31 1.64b ±0.21
Diﬀerent letters “a” to “d” in the column represents that values are signiﬁcantly diﬀerent when compared between ulcer induced with healthy control and
GRAE/lansoprazole-treated groups.
Table 2: Anti-oxidant/anti-oxidant enzymes and TBARS levels in swim ethanol-induced ulcer model (n = 6) mean ± SD.
Parameters Protein (mgg−1) SOD (Umg−1) Catalase (Umg−1) Glutathione
Peroxidase (nmolg−1)
GSH (Umg−1)T B A R S n m o l
Stomach
Healthy 2.23a ±0.21 078.8a ±07 48.2c ±6.2 26.5a ±2.3 368.2c ±42 0.76a ±0.06
Ulcerated 2.32a ±0.09 218.3d ±20 21.6a ± 2.2 76.6c ± 6.0 208.4a ±21 1.93c ±0.21
GRAE 100mgkg−1 2.38a ±0.24 156.9c ±16 36.1b ±3.8 56.9b ±6.4 286.6b ±27 0.96b ±0.08
GRAE 200mgkg−1 2.42a ±0.26 128.3b ±11 39.2b ±4.1 28.3a ±3.1 342.2c ±36 0.87ab ±0.10
Lansoprazole 2.42a ±0.19 168.6c ±1.63 8 .2b ±1.4 25.2a ±2.03 252b ±16 0.96ab ± 0.2
Serum
Healthy 3.62a ±0.51 112.3a ±28 44.20c ±4.9a 0.221a ±0.04 23.6d ±3.00 .165a ±0.01
Ulcerated 6.52a ±0.69 282.3d ±26 28.36a ±3.2b 0.315c ± 0.03 09.6a ±1.20 .465d ±0.03
GRAE 100mgkg−1 6.58a ±0.62 198.6c ±22 33.45ab ±4.1b 0.264b ±0.02 15.4c ±1.20 .312c ±0.03
GRAE 200mgkg−1 6.62a ±0.67 136.4b ±18 42.34b ±3.3a 0.251b ±0.02 22.5c ±2.10 .172a ±0.02
Lansoprazole 6.32a ±0.69 210.7c ±28 34.12ab ±4.6b 0.252b ±0.03 14.6b ±1.60 .214ab ± 0.02
Liver
Healthy 24.2a ±0.31 261.5b ±1.12 8 .42c ±3.1 0.32b ±0.02 414c ±51 0.98a ±0.13
Ulcerated 24.3a ±0.31 118.1a ±16 19.64b ±2.2 0.48b,c ±0.03 392b,c ±41 2.98d ±0.31
GRAE 100mgkg−1 26.4a ±0.23 127.4a ±12 22.32b ±2.3 0.43b ±0.04 365b ±34 2.63c ±0.24
GRAE 200mgkg−1 26.8a ±0.25 238.3c ±24 25.23a ±2.6 0.36a ±0.03 396a,b ±36 1.36b ±0.13
Lansoprazole 26.8a ±0.29 254.5b ±26 14.24a ±1.8 0.31a ±0.03 211a ±28 1.61b ±0.16
Diﬀerent letters “a” to “d” in the column represents that values are signiﬁcantly diﬀerent when compared between ulcer induced with healthy control and











Figure 2: Eﬀect of GRAE on H. pylori growth. Anti-H. pylori activity was tested by the standard agar diﬀusion method (a). A 5.5 mm
discs containing 10μg each of Amoxicillin-a known antibiotic (a.2); GRAE were impregnated with agar and (a.1) served as control with no
inhibitor disc. Clear area around the disc represents the inhibition zone due to the eﬀect of the test fraction. (b)–(f) indicate the scanning
electron microscopic pictures at 15k magniﬁcation of control (b), amoxicillin (c), GRAE (d) treated H. pylori and (e) and (f) depicts the
H. pylori treated with pure phenolic acids gallic and cinnamic acid respectively. Untreated control cultures indicate uniform rod shaped H.
pylori cells. Amoxicillin treatment showed coccoid form, blebbing, fragmented and lysed cells. Similar altered conditions observed in GRAE
and pure phenolics treated H. pylori cells. ∗Figures were taken from our previous paper [14] for the comparative purpose.
comparative purpose, two phenolic acids—gallic acid and
cinnamic acids that showed poorer and potent H+,K +-
ATPase inhibitory activity respectively, were examined in
presence and absence of gallic/cinnamic acids and expressed
as Sterner’s constant.
Results from HSA interaction studies indicated that the
changes occurred in the environment of tryptophan residues
in HSA and was dependent on the applied phenolic acids.
As shown in Figure 6, both gallic and cinnamic acids showed



























































































Figure 3: HPLC analysis of phenolic acid constituents in GRAE.
A 1mgmL−1 solution of GRAE (a.3) was prepared, after vortexing
for 10min at room temperature with the mobile phase-water/acetic
acid/methanol—80:5:15 (v/v/v)—Isocratic and 20μLo fe a c hw a s
loaded on to HPLC Shimpak C18 column (4.6 × 250mm, Shi-
madzu Corp, Kyoto, Japan). A 20μLo fm gm L −1 standard phenolic
acids were loaded independently and their speciﬁc retention time
(min) was established. Phenolic acids in GRAE were identiﬁed
comparing with their retention time with known standards.
gallic acid were found to be 0.024 × 106 M−1 and 0.016
× 106 M−1, respectively. Approximately 1.5-fold increase
in binding was observed with cinnamic acid than gallic
acid. However, 5-fold better H+,K +-ATPase inhibition with
cinnamic acid than gallic acid suggests that parameters other
than binding may also inﬂuence H+,K +-ATPase inhibitory
activity in case of cinnamic acid. Cinnamic acid being
hydrophobic, may access the membrane domain of H+,K +-
ATPase which is lacking in HSA, may possibly accounted for
enhanced inhibitory activity.
4. Discussion
Ulcer results from an imbalance between aggressive factors
and the maintenance of mucosal integrity through the
endogenous defense mechanisms. To regain the balance,
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Figure 4: Anti-oxidant potency of GRAE. Concentration of 5–
25μgGAE/mLofGRAEwereexaminedforreducingpower(a),free
radical scavenging (b) and inhibition of lipid peroxidation (c) as
per the protocol described under materials and methods section.
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Figure 5: DNA protection ability of GRAE. One microgram of
native calf thymus DNA in (lane 1); DNA treated with Fenton’s
reagent (lane 2); DNA pre-treated with 2, 4, 6μg of GRAE (lanes
3–5) were loaded on to the 1% agarose gel. Bands were visualized
by staining with ethidium bromide and in the transilluminator
increased mobility represents DNA damage.
been used. In the previous paper, we had shown that free and
bound phenolics of ginger possessed potential ulcer preven-
tive activity in vitro, including inhibition of H+,K +-ATPase
and H. pylori growth [9]. However, in view of addressing
a question whether the traditional practice of using crude
ginger extract in either boiled water or cold water extract
can yield compounds which are gastroprotective in nature;
we evaluated in vitro and in vivo ulcer-preventive properties
of GRAE and determined whether it also contained phenolic
acidsthatfavorsgastroprotectionasreportedinourprevious
papers [9, 17].
ROS are implicated in the pathogenesis of several
diseases. Free radicals are continuously produced during
normal physiologic events and removed by anti-oxidant
defense mechanisms, including enzymes such as SOD, CAT
and enzymes involved in the glutathione redox cycle. Free
radicals cause lipid peroxidation and production of highly
toxic lipid derivatives, which in turn can modify cell func-
tionsandevenmayleadtocelldeath.Oxidative modiﬁcation
of proteins may result in structural impairment and also
change their functional properties such as their involvement
in signaling, critical for numerous cellular functions. They
aﬀect the vasomotor function of vasculature throughout the
body via alterations in the activity of the autonomic nervous
system, thus changing the blood ﬂow to involve tissues such
as mucosa. Oxidative stress (OS) being major source in caus-
ing ROS-mediated ulceration, up/down regulation of anti-
Table 3: Gastric mucin and H+,K +-ATPase levels in healthy,
ulcerated and protected rats (n = 6) mean ± SD.







Healthy 62.05d ±5.10 .721a ±0.02
Swim stress-induced ulcer model
Swim stress induced 18.42a ±3.42 .610d ±0.21
GRAE 100mgkg−1 b.w. 43.36b ±3.61 .316c ±0.18
GRAE 200mgkg−1 b.w. 48.41b,c ±3.40 .831a ±0.14
Lansoprazole 30mgkg−1 b.w. 35.14b ±2.41 .220b ±0.12
Ethanol stress-induced ulcer model
Ethanol stress induced 22.37a ±2.32 .318c ±0.24
GRAE 100mgkg−1 b.w. 36.32b ±3.61 .213b ±0.26
GRAE 200mgkg−1 b.w. 46.54c ±3.80 .793a ±0.08
Lansoprazole 30mgkg−1 b.w. 33.23b,c ±2.41 .240b ±0.12
Diﬀerent letters “a” to “d” in the column represents that values are
signiﬁcantly diﬀerent when compared between ulcer induced with healthy
control and GRAE/lansoprazole-treated groups. Range was provided by
Duncan multiple test at P<. 05. aLess signiﬁcant; bModerately signiﬁcant;
cVery signiﬁcant and dMost signiﬁcant.
Table 4: Toxicity studies with GRAE (n = 6) mean ± SD.
Parameters Control GRAE treated
Total protein 348a ±32.21 358.43a ± 22.1
SGOT (Umg−1 protein) 18.34a ±1.55 16.86a ±1.64
SGPT (Umg−1 protein) 21.31a ±2.70 18.91a ±2.42
ALP (Umg−1 protein) 35.52a ± 3.879 36.82a ±2.91
TBARS (nmolmg−1 protein) 0.166a ±0.08 0.148a ±0.09
SGPT, Serum glutamate pyruvate transaminase; SGOT, Serum glutamate
oxaloacetate transaminase; ALP, Alkaline phosphatase. aP<. 05 between
control and GRAE-treated groups.
oxidant/anti-oxidative enzymes reveal the ability of GRAE to
counteract the OS condition and hence protection to ulcer.
GRAEat200mgkg−1 b.w.protectedswimstress/ethanol-
induced ulcer lesions up to 86% similar to that of lanso-
prazole (80%), a known antiulcer drug at 30mgkg−1 b.w.
Bloody streaks, inﬂammations, oozing of blood into the
lumen of the stomach, and so forth, observed in ulcerous
animals were not found in GRAE ingested animals, similar
to those of healthy rats indicating the gastroprotective
eﬀect of GRAE. Further, we followed the protective eﬀect
investigating the biochemical parameters such as alterations
in the gastric mucin, oxidants, GSH, H+,K +-ATPase and
anti-oxidant enzymes level including CAT, SOD, peroxidase,
and so forth, in the ulcerated organ—stomach as well in
the metabolizing organ—liver in all groups of rats—healthy,
ulcerated and GRAE/lansoprazole treated. Preventive anti-
oxidant enzymes such as SOD and CAT are the ﬁrst line of
defense against ROS. Administration of GRAE resulted inEvidence-Based Complementary and Alternative Medicine 11
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Helicobacter pylori obtained from endoscopic excision was subjected to
various biochemical tests to conﬁrm the identity of isolated bacteria as
H. pylori. Gram staining, enzyme analysis and morphological analysis as
well as antibiotic resistance/susceptibility were included in the tests for
characterization of H. pylori.
a signiﬁcant increase in the SOD, CAT and reduced GSH
levels (Tables 1 and 2) similar to those of control animals,
suggesting the eﬃcacy of GRAE in preventing free radical-
induced damage during ulceration. SOD, GPx, CAT and
GSH all contribute to maintain anti-oxidant status during
oxidative stress condition such as ulcers. SOD and GPx levels
were increased during ulceration to scavenge superoxide
and peroxy radicals generated during ulceration. Depletion
in CAT and reduced GSH suggest the utilization of these
components towards the neutralization of increased free
radicals.
In our experimental model, ∼3.4-fold reduction in
gastricmucinand2.4-foldreducedglutathioneaswellas2.6-
fold increased oxidative product—TBARS in the stomach
were normalized by GRAE (Tables 1–3) treatment. Gastric
ulcers are often a chronic disease and it may persist for 10–
20 years as characterized by repeated episodes of healing and
re-exacerbations [23]. Stress-induced ulcer better resembles
clinical ulcers in chronicity, severity and practicality of
experiencing stress due to varietal patterns of lifestyle in
day to day life and serves the most reliable model to study
ulcer healing process [24, 25]. The incidence of swim stress-
induced ulcer is predominant in the glandular part of the
stomach leading to gastric mucosal/mucin damage. GRAE
signiﬁcantly prevented ulcers both by reducing the oxidative
stress as well as boosting the mucosal defense.
Further, during our study, we evaluated the possible
mechanism of protection to gastric ulcer apart from up-
regulation of anti-oxidant and anti-oxidant enzyme levels.
Gastric H+,K +-ATPase located in the apical membrane of
parietal cells, pumps protons into the gastric lumen, using
energy derived from the hydrolysis of ATP, and is thus
involved in gastric acid secretion. Accordingly, the activity
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Figure 6: Fluorescence emission spectra of HSA in the presence
of gallic acid and cinnamic acid. The extinction wave length was
280nm. Both excitation and emission slits widths were 5nm. Inlaid
ﬁgure—Stern-Volmer plots (x-axis: concentration in micrograms;
y-axis: F0/F).
homogenate, which showed 3-fold up-regulation of the
enzyme in ulcer condition and was normalized by treatment
with GRAE (Table 3). Results were further substantiated by
sheep H+,K +-ATPase inhibition by GRAE with an IC50
of 16.5 ± 1.2μgmL −1 on par or better than lansoprazole
(19.3 ± 2.2μgw/w), indicating the potential multi-targeted
eﬀect of GRAE in preventing swim stress-induced ulcers in
experimental rats. GRAE may ﬁnd itself more useful as a
H+,K +-ATPase (proton pump) inhibitor than the existing12 Evidence-Based Complementary and Alternative Medicine
Table 6: Relative percentage contribution of individual phenolic acids towards anti-oxidant, anti-H. pylori and H+,K +-ATPase inhibition.
GRAE Phenolics (mgg−1) AOX (% contribution) PPI (% contribution) Hp y l o r i -inhibition (% contribution)
Gallic acid 3.4 93 9 66
Cinnamic acid 3.8 1 88 30
Other phenolics 0.4 6 3 4
Gallic acid signiﬁcantly contributed to anti-oxidant activity than cinnamic acid where as cinnamic acid contributed to H+,K +-ATPase inhibition.
pump inhibitors, since they have adverse eﬀects as reported
particularly under conditions of pregnancy/lactation and
alcohol or any other drug consumption. Least toxicity of
GRAE may also ﬁnd GRAE as useful alternative source for
ulcer healing therapeutics.
Besides, GRAE also exhibited the anti-H. pylori activity.
The MIC values obtained conﬁrmed the signiﬁcant (P =
.003) anti-H. pylori activity, and as reported in previous
papers results were supported by an observation of Vattem
et al. [18], where phenolic phytochemicals such as cinnamic
acid, cinnamaldehyde, coumarins and ﬂavonoids have been
suggested to exhibit high anti-H. pylori activity. GRAE with
higher content of cinnamic acid showed better inhibition
of H. pylori. As mentioned in earlier studies, phenolics
were thought to exert their anti-microbial eﬀect by causing
(i) hyperacidiﬁcation at the plasma membrane interface of
the microorganism [26] or (ii) intracellular acidiﬁcation,
resulting in disruption of H+,K +-ATPase required for ATP
synthesis of microbes [27] or (iii) may be related to inacti-
vation of cellular enzymes causing membrane permeability
changes [27].
Also, it is intriguing to observe that cinnamic acid is act-
ing asapotent inhibitor ofH+,K +-ATPase,andalsoH.pylori
probably by stronger binding of cinnamic acid to membrane
domains of H+,K +-ATPase and H. pylori than gallic acid,
which is a poor inhibitor of H+,K +-ATPase and H. pylori
(Figure 6). Lack of correlation between fold inhibitory activ-
ity versus binding between gallic/cinnamic acid still do not
rule out the proposed mechanism. Because being hydropho-
biccinnamicacidbindingabilitymaybehigherwithH+,K +-
ATPase and H. pylori which carry membrane domains than
HSA alone which is devoid of this hydrophobic domain.
GRAE also exhibited reducing power and prevented free
radical-induced lipid and DNA peroxidation. This anti-
oxidative property also contributes signiﬁcantly to reduce
ulcer condition and justiﬁes the ethno medical claims.
Table 6 shows the relative concentration of individual phe-
nolic acids towards the antiulcer activity. Our data in the
present and previous papers indicate that cinnamic acid,
caﬀeic acid and p-coumaric acids contribute signiﬁcantly to
inhibition of H+,K +-ATPase and H. pylori growth in the
free as well as in the bound form. Recently, we also reported
the role of cinnamic acid in cross-linking property of pectic
polysaccharide and its contribution hence to the structural
stability (manuscript communicated).
5. Conclusions
The present study clearly demonstrated that aqueous extract
of ginger was able to protect the gastric mucosa from stress-
induced mucosal lesions and inhibits gastric acid secretion
probably by blocking H+,K +-ATPase action, inhibiting
growth of H. pylori and oﬀering anti-oxidant protection
against oxidative stress-induced gastric damage The results
conﬁrmthepopularuseofgingerforitsmedicinalproperties
in Ayurveda and folklore medicines. These results further
suggest the use of ginger for gastric disorders that needs to be
considered as possibilities for new therapeutic approaches.
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